Erosio Interdigitalis Blastomycetica (EIB) is a relatively uncommon but clinically significant superficial fungal infection that primarily affects the web spaces between the fingers and toes. First described in 1915 by French dermatologists Gougerot and Goncea, EIB is a manifestation of candidal intertrigo—a skin condition caused by the overgrowth of Candida species, particularly Candida albicans, in moist, occluded areas of the body. Though often overlooked, EIB can cause considerable discomfort and may lead to secondary infections if not properly managed.

Etiology and Pathogenesis

EIB is caused by Candida albicans, a yeast-like fungus that is part of the normal flora of the human skin, gastrointestinal tract, and mucous membranes. Under normal conditions, Candida exists harmlessly in small quantities. However, when the balance of microbial flora is disrupted—due to factors such as excessive moisture, heat, friction, or immunosuppression—Candida can proliferate and invade the superficial layers of the skin.

The condition typically arises in the interdigital spaces, especially between the third and fourth fingers or toes. These areas are particularly susceptible due to their anatomical configuration, which promotes moisture retention and friction. The warm, damp environment of skin folds creates an ideal breeding ground for Candida, facilitating its overgrowth and subsequent infection.

Risk Factors

Several predisposing factors contribute to the development of EIB. These include:

• Moisture and Occlusion: Frequent exposure to water or occlusive environments, such as wearing tight gloves or non-breathable footwear, increases the risk of infection.
• Poor Hygiene: Inadequate drying of the hands or feet after washing can leave residual moisture, promoting fungal growth.
• Occupational Exposure: Individuals whose professions involve frequent hand immersion in water—such as bartenders, homemakers, healthcare workers, and dishwashers—are particularly vulnerable Wikipedia.
• Immunosuppression: Conditions like diabetes mellitus, HIV/AIDS, or the use of immunosuppressive medications can impair the body’s ability to control fungal proliferation.
• Use of Occlusive Products: Overuse of emollients or petroleum-based products in moist areas can exacerbate the condition by trapping moisture.

Clinical Presentation

EIB typically presents as an oval or crescent-shaped area of macerated, white, and soggy skin located between the fingers or toes. The affected area may extend onto the adjacent sides of the digits. Common symptoms include:

• Pruritus (itching)
• Burning or stinging sensation
• Redness and inflammation
• Foul odor in severe cases
• Occasional pain or tenderness

In chronic or untreated cases, the skin may become fissured or eroded, increasing the risk of secondary bacterial infections. The condition is often bilateral and symmetrical, particularly in individuals with occupational exposure.

Diagnosis

Diagnosis of EIB is primarily clinical, based on the characteristic appearance of the lesions and patient history. However, laboratory tests can confirm the diagnosis and rule out other conditions. These may include:

• Potassium Hydroxide (KOH) Preparation: A skin scraping examined under a microscope after KOH treatment can reveal budding yeast cells and pseudohyphae.
• Fungal Culture: Culturing the organism on Sabouraud dextrose agar can help identify Candida species.
• Wood’s Lamp Examination: Although Candida does not fluoresce under ultraviolet light, this test can help exclude other fungal infections like tinea.

Differential diagnoses include tinea pedis or manuum (caused by dermatophytes), bacterial intertrigo, eczema, and contact dermatitis. Accurate diagnosis is crucial, as treatment regimens differ depending on the causative organism DermNet.

Treatment

The cornerstone of EIB treatment involves both antifungal therapy and modification of predisposing factors. Treatment strategies include:

• Topical Antifungals: First-line therapy typically involves topical agents such as clotrimazole, miconazole, or ketoconazole creams. These are applied twice daily for 2–4 weeks.
• Oral Antifungals: In severe or recurrent cases, systemic antifungals like fluconazole or itraconazole may be prescribed.
• Drying Agents: Solutions like Burow’s solution (aluminum acetate) can help dry out the macerated skin and reduce inflammation.
• Hygiene Measures: Keeping the affected area clean and dry is essential. Patients should be advised to dry the interdigital spaces thoroughly after washing and avoid occlusive gloves or footwear.
• Barrier Protection: Use of absorbent powders or moisture-wicking socks can help reduce humidity in the affected areas.

Prevention

Preventing EIB involves addressing the environmental and behavioral factors that contribute to its development. Preventive measures include:

• Practicing good hand and foot hygiene
• Thoroughly drying interdigital spaces after bathing or washing
• Wearing breathable gloves and footwear
• Changing socks regularly, especially after sweating
• Avoiding overuse of occlusive creams in moist areas
• Managing underlying conditions like diabetes or immunosuppression

Education plays a vital role in prevention, particularly for individuals in high-risk occupations. Employers should provide appropriate protective equipment and encourage regular breaks to allow skin to dry.

Prognosis and Complications

With appropriate treatment and preventive measures, the prognosis for EIB is excellent. Most cases resolve within a few weeks of initiating therapy. However, recurrence is common if predisposing factors are not addressed. Chronic or recurrent EIB can lead to complications such as:

• Secondary bacterial infections (e.g., cellulitis)
• Chronic dermatitis
• Nail involvement (onychomycosis)
• Psychological distress due to persistent symptoms

Early recognition and intervention are key to preventing these complications and improving patient outcomes.

Erosio Interdigitalis Blastomycetica is a distinctive form of candidal intertrigo that underscores the importance of skin care in moist and occluded environments. Though often benign, it can significantly impact quality of life and occupational performance if left untreated. A combination of antifungal therapy, environmental modification, and patient education forms the foundation of effective management. As awareness of EIB grows among healthcare providers and the general public, timely diagnosis and intervention can help reduce its burden and prevent recurrence.